1. Home
  2. TRNO vs BIO Comparison

TRNO vs BIO Comparison

Compare TRNO & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Terreno Realty Corporation

TRNO

Terreno Realty Corporation

HOLD

Current Price

$65.87

Market Cap

7.0B

Sector

Finance

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$312.45

Market Cap

6.9B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRNO
BIO
Founded
2009
1952
Country
United States
United States
Employees
N/A
7450
Industry
Real Estate
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
7.0B
6.9B
IPO Year
2009
N/A

Fundamental Metrics

Financial Performance
Metric
TRNO
BIO
Price
$65.87
$312.45
Analyst Decision
Buy
Buy
Analyst Count
12
4
Target Price
$67.83
$339.75
AVG Volume (30 Days)
603.5K
471.8K
Earning Date
05-05-2026
04-30-2026
Dividend Yield
3.21%
N/A
EPS Growth
103.65
N/A
EPS
0.66
N/A
Revenue
$476,383,000.00
N/A
Revenue This Year
$8.42
$2.74
Revenue Next Year
$9.10
$3.20
P/E Ratio
$100.91
$9.72
Revenue Growth
24.51
N/A
52 Week Low
$53.00
$211.43
52 Week High
$67.55
$343.12

Technical Indicators

Market Signals
Indicator
TRNO
BIO
Relative Strength Index (RSI) 50.88 68.29
Support Level $64.01 $293.88
Resistance Level $67.03 $330.54
Average True Range (ATR) 1.13 9.86
MACD -0.00 6.66
Stochastic Oscillator 52.52 90.63

Price Performance

Historical Comparison
TRNO
BIO

About TRNO Terreno Realty Corporation

Terreno Realty Corp is a real estate investment trust engaged in acquiring, owning, and operating industrial real estate in six coastal U.S. markets: Los Angeles, Northern New Jersey/New York City, San Francisco Bay Area, Seattle, Miami, and Washington, D.C. The company invests in several types of industrial real estate, including warehouse/distribution, flex (including light industrial and research and development), transshipment, and improved land.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: